FIELD: medicine.
SUBSTANCE: disclosed is a composition for treating a lysosomal storage disease, comprising a recombinant glycoprotein, which is human β-glucuronidase and having a degree of sialylation of about 1.1 mol/mol.
EFFECT: invention provides high content of sialic acid in the glycoprotein for pharmacological application.
9 cl, 7 dwg, 6 tbl, 3 ex
| Title |
Year |
Author |
Number |
| COMPOSITION FOR CONTROLLED OVARIAN STIMULATION |
2012 |
|
RU2613324C2 |
| COMPOSITION FOR CONTROLLED OVARIAN STIMULATION |
2012 |
|
RU2739037C2 |
| RECOMBINANT FOLLICLE-STIMULATING HORMONE (FSH) CONTAINING ALPHA-2,3- AND ALPHA-2,6-SYALILATION |
2009 |
- Cottingham Ian
- Plaksin Daniel
- White Richard Boyd
|
RU2682270C2 |
| Recombinant follicle-stimulating hormone (FSH), including alpha-2,3 - and alpha-2,6-sialation |
2018 |
- Cottingham Ian
- Plaksin Daniel
- White Richard Boyd
|
RU2745557C1 |
| METHOD FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES |
2011 |
- Stedkhim Terrans A.
- Chzha Dunsin
- Lju Limin
|
RU2604811C2 |
| RECOMBINANT FOLLICLE-STIMULATING HORMONE (FSH) CONTAINING ALPHA-2, 3- AND ALPHA-2, 6-SYALILATION |
2009 |
- Kottingkhem, Ian
- Plaksin, Daniehl'
- Uajt, Richard Bojd
|
RU2537268C2 |
| PHARMACEUTICAL PREPARATION CONTAINING RECOMBINANT HUMAN CHORIONIC GONADOTROPIN |
2010 |
- Cottingham Ian
- Plaksin Daniel
- White Richard Boyd
|
RU2588650C2 |
| RECOMBINANT GLYCOPROTEINS WITH SIALYLATED O-GLYCANS AND CELL LINES FOR THEIR PRODUCTS |
2015 |
- Faust, Nicole
- Woelfel, Jens
- Wissing, Silke
|
RU2714209C2 |
| PHARMACEUTICAL PREPARATION CONTAINING RECOMBINANT HCG (HUMAN CHORIONIC GONADOTROPIN HORMONE) |
2010 |
- Cottingham Ian
- Plaksin Daniel
- White Richard Boyd
|
RU2724528C2 |
| METHODS RELATING TO MODIFIED GLYCANS |
2009 |
- Boskes Karlos Dzh.
- Merfi Dzhennifer Linn
- Gunaj Sibel Nur
- Shrajver Zakari
- Lju Tsujkhua
|
RU2526250C2 |
